Rocket Pharmaceuticals, Inc.
  1. Companies
  2. Rocket Pharmaceuticals, Inc.
  3. Products
  4. Infantile Malignant Osteopetrosis (IMO)

Infantile Malignant Osteopetrosis (IMO)

SHARE

In January 2022, Rocket disclosed plans return the program back to academic collaborators in order to reallocate resources to Rocket’s pipeline.